A002210 Stock Overview
Manufactures and sells pharmaceuticals and cosmetics in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Dong Sung Bio Pharm.Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩4,405.00 |
| 52 Week High | ₩6,310.00 |
| 52 Week Low | ₩4,255.00 |
| Beta | 0 |
| 11 Month Change | -0.90% |
| 3 Month Change | -2.76% |
| 1 Year Change | -28.02% |
| 33 Year Change | -46.08% |
| 5 Year Change | -70.14% |
| Change since IPO | 11.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| A002210 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -1.0% | -0.9% | 0.9% |
| 1Y | -28.0% | 7.7% | -3.4% |
Return vs Industry: A002210 underperformed the KR Pharmaceuticals industry which returned 7.7% over the past year.
Return vs Market: A002210 underperformed the KR Market which returned -3.4% over the past year.
Price Volatility
| A002210 volatility | |
|---|---|
| A002210 Average Weekly Movement | 1.4% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A002210 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A002210's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1957 | n/a | Yang-Gu Lee | dongsung-pharm.com |
Dong Sung Bio Pharm.Co.,Ltd. manufactures and sells pharmaceuticals and cosmetics in South Korea. The company offers over the counter drugs, such as emollient, vitamin supplement, alopecia treatment, antihistamines, liver disease treatment, fire extinguisher solvent, antiviral, eye drops, menopause treatment, sleep inducer, antipyretic, analgesic, anti-inflammatory, vascular reinforcement, broad-spectrum skin disease treatment, gum disease treatment, blood circulation improver, scar treatment, dry stomach, eye nourishment, abdominal obesity treatment, anti-soil agent, respiratory solvent, and antifungal agent.
Dong Sung Bio Pharm.Co.,Ltd. Fundamentals Summary
| A002210 fundamental statistics | |
|---|---|
| Market cap | ₩101.75b |
| Earnings (TTM) | ₩1.70b |
| Revenue (TTM) | ₩78.44b |
0.0x
P/E Ratio0.0x
P/S RatioIs A002210 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A002210 income statement (TTM) | |
|---|---|
| Revenue | ₩78.44b |
| Cost of Revenue | ₩33.23b |
| Gross Profit | ₩45.21b |
| Other Expenses | ₩43.51b |
| Earnings | ₩1.70b |
Last Reported Earnings
Dec 31, 2011
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A002210 perform over the long term?
See historical performance and comparison